As of December 2025 Galectin Therapeutics has a market cap of ยฃ0.28 Billion. This makes Galectin Therapeutics the world's 7602th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 9th, 2025 the market cap of Galectin Therapeutics was reported to be: